Pluri Inc. Logo

Pluri Inc.

Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.

PLUR | TA

Overview

Corporate Details

ISIN(s):
US72942G2030
LEI:
Country:
Israel
Address:
Park Building No. 5, 3508409 Haifa

Description

Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-06-02 01:19
FORM S-3-REGISTRATION STATEMENT
English 36.1 KB
2023-05-10 01:55
Form 10-Q -March 31, 202 3Financial Results
English 2.0 MB
2023-05-10 01:55
Form 10-Q -March 31, 202 3Financial Results
English 36.2 KB
2023-04-28 01:31
Results of stockholder voting at the 2023 Annual Meeting held on April 27, 2023
English 197.1 KB
2023-04-28 01:31
Results of stockholder voting at the 2023 Annual Meeting held on April 27, 2023
English 36.1 KB
2023-04-27 16:01
Unveils PluriMatrix: a Breakthrough System for Unprecedented Industrial Scale P…
English 576.5 KB
2023-04-27 16:01
Unveils PluriMatrix: a Breakthrough System for Unprecedented Industrial Scale P…
English 36.1 KB
2023-04-26 01:12
received a Notice from Nasdaq regurding the $1.00 per share minimum required fo…
English 139.2 KB
2023-04-26 01:12
received a Notice from Nasdaq regurding the $1.00 per share minimum required fo…
English 36.2 KB
2023-03-13 15:00
Israel’s Ministry of Labor Names Pluri as Winner of the 2022 Egalitarian Employ…
English 93.0 KB
2023-03-13 15:00
Israel’s Ministry of Labor Names Pluri as Winner of the 2022 Egalitarian Employ…
English 36.2 KB
2023-02-27 17:42
2022 ANNUAL REPORT
English 330.4 KB
2023-02-27 17:42
2022 ANNUAL REPORT
English 36.1 KB
2023-02-27 17:37
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held On April 27, 2023
English 112.7 KB
2023-02-27 17:37
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held On April 27, 2023
English 282.2 KB

Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pluri Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pluri Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.